Bayer Acquires Biologics Platform, Deals With Pfizer, MedImmune
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the In Vivo blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
The Xenazine Model: Big Things Come In Small Packages
The Huntington's chorea therapy Xenazine (tetrabenazine) is being used by just over 1,000 patients after three months on the market, and Biovail couldn't be happier
GSK Diversifies With Deal That Allows Bristol To Divest Non-Core Unit
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: